The radiosensitizing effect of CDK4/6 inhibitor, observed in preclinical studies [14,15], is attributed to their ability to inhibit DNA damage repair induced by RT and therefore increasing tumor cytotoxicity. This evidence concerns the gene CDK4 and neoplasm.